(Q37603342)

21 August 2017

1 reference

title

Darinaparsin: a novel organic arsenical with promising anticancer activity (English)

1 reference

21 August 2017

3

Izidore S Lossos

1 reference

21 August 2017

Koren K Mann

1

1 reference

21 August 2017

Barbara Wallner

series ordinal

2

1 reference

21 August 2017

Wilson H Miller

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Expert Opinion on Investigational Drugs

21 August 2017

published in

1 reference

21 August 2017

volume

18

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1727-1734

1 reference

History of the development of arsenic derivatives in cancer therapy

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Introduction: the history of arsenic trioxide in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

The expanding role of arsenic in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Chemical and clinical development of darinaparsin, a novel organic arsenic derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Glutathione levels and variability in breast tumors and normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

21 January 2018

Combined chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903282759

10.1517/13543780903282759

21 January 2018

Identifiers

DOI

1 reference

release_qhmcpfsdqnhgvacr4dlo6mvxym

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qhmcpfsdqnhgvacr4dlo6mvxym

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference